Editorial: Viral vector-based gene therapy in neurological disease: The future is now.

Smith JB, Cancedda L, Jozwiak S, Mercer AC

Open source

DOI
10.3389/fneur.2023.1153681
Published
2023
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2023.1153681,
  title = {Editorial: Viral vector-based gene therapy in neurological disease: The future is now.},
  author = {Smith JB and Cancedda L and Jozwiak S and Mercer AC},
  year = {2023},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2023.1153681},
  url = {https://doi.org/10.3389/fneur.2023.1153681}
}

RIS

TY  - JOUR
TI  - Editorial: Viral vector-based gene therapy in neurological disease: The future is now.
AU  - Smith JB
AU  - Cancedda L
AU  - Jozwiak S
AU  - Mercer AC
PY  - 2023
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2023.1153681
UR  - https://doi.org/10.3389/fneur.2023.1153681
ER  - 

APA

JB, S., L, C., S, J., & AC, M. (2023). Editorial: Viral vector-based gene therapy in neurological disease: The future is now.. Frontiers in neurology. https://doi.org/10.3389/fneur.2023.1153681

Source records